XML 26 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities      
Net loss $ (74,363) $ (48,133) $ (31,148)
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation 252 73 64
Amortization and accretion costs related to notes payable—related parties 0 0 3,207
Amortization of deferred financing costs and debt discount 305 77 0
Amortization and accretion of premium or discount on available-for-sale investments, net 570 416 0
Interest payable—related parties 0 0 588
Loss (gain) on conversion of notes payable 0 0 2,737
Stock-based compensation 12,945 9,178 2,858
Change in fair value measurements 0 0 3,717
Changes in operating assets and liabilities      
Prepaid, current and other assets (840) (717) (516)
Accounts payable and other current liabilities 5,385 4,829 2,045
Interest payable 0 551 0
Net cash used in operating activities (55,746) (33,726) (16,448)
Cash flows from investing activities      
Purchase of available-for-sale investments (46,872) (95,376) 0
Maturity of available-for-sale investments 55,785 20,739 0
Sale of available-for-sale investments 3,749 1,500 0
Purchase of furniture, fixtures and equipment (3,280) (181) (63)
Net cash provided by (used in) investing activities 9,382 (73,318) (63)
Cash flows from financing activities      
Proceeds from sale of common stock, net of commissions 50,451 0 0
Proceeds from exercise of stock options 1,282 9 1
Proceeds from exercise of stock purchase rights 96 119 0
Proceeds from exercise of warrants 9 0 8
Payments of debt issuance costs 0 122,853 0
Payments of initial public offering costs 0 0 71,870
Proceeds from notes payable to related parties 0 0 (3,644)
Proceeds from notes payable to related parties 0 0 15,000
Net cash provided by financing activities 51,838 122,981 83,235
Net change in cash and cash equivalents 5,474 15,937 66,724
Cash and cash equivalents      
Beginning of period 85,586 69,649 2,925
End of period 91,060 85,586 69,649
Supplemental disclosures      
Interest paid 2,186 0 0
Income taxes paid 600 0 0
Non-cash financing activities      
Conversion of preferred stock to common stock 0 0 61,348
Conversion of convertible notes payable and accrued interest to common stock 0 0 18,604
Issuance of common stock upon net exercise of warrants 0 0 4,888
Reclassification of warrants from liabilities to equity 0 0 6,560
Accretion from conversion of note payable to related parties 0 0 240
Accretion of stock issuance costs 0 0 210
Deferred costs from issuance of convertible notes $ 0 $ 25 $ 0